Surgical resection is the primary and most effective treatment for most patients with solid
tumors. However, patients suffer from postoperative recurrence and metastasis. In the past …

With the advent of the era of precision medicine, prostate‐specific membrane antigen
(PSMA)‐targeted theranostic strategies have had a profound impact on prostate cancer …

Prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein located on the
cell membrane, is specifically and highly expressed in prostate cancer (PCa). Besides, its …

Prostate cancer is one of the most common cancers and among the leading causes of
cancer deaths in the United States. Men diagnosed with the disease typically undergo …

The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic
strategies. Prostate tumors specifically express the prostate‐specific membrane antigen …

Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is highly
expressed in aggressive prostate cancer (PCa) and has been extensively studied as a PCa …

For over a hundred years, X‐rays have been a main component of the radiotherapeutic
approaches to treat cancer. Yet, to date, no radiosensitizer has been developed to …

Since the introduction of PSA testing, significantly more men have been diagnosed and
treated for prostate cancer. Localized prostate cancer typically is treated with prostatectomy …

Photodynamic therapy (PDT), in which a light source is used in combination with a
photosensitizer to induce local cell death, has shown great promise in therapeutically …

Simple Summary Photodynamic therapy (PDT) is a minimally invasive treatment option that
can kill cancerous cells by subjecting them to light irradiation at a specific wavelength. The …